Susanne Gonder

Luxembourg, LU L1445, Luxembourg

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Restoring NK Cell Cytotoxicity Post-Cryopreservation via Synthetic Cells.

Restoring NK Cell Cytotoxicity Post-Cryopreservation via Synthetic Cells.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 30, 2025

Eμ-TCL1 adoptive transfer mouse model of chronic lymphocytic leukemia.

Eμ-TCL1 adoptive transfer mouse model of chronic lymphocytic leukemia.

Journal: Methods in cell biology

Published: June 16, 2024

Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.

Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.

Journal: Nature communications

Published: January 29, 2024

Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice.

Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice.

Journal: Cancer immunology, immunotherapy : CII

Published: October 11, 2023

Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia.

Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia.

Journal: Haematologica

Published: November 22, 2022

Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.

Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.

Journal: Blood

Published: July 18, 2022

Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses.

Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses.

Journal: Blood cancer discovery

Published: February 24, 2022

The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia.

The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia.

Journal: Cancers

Published: August 20, 2021

Method for the Analysis of the Tumor Microenvironment by Mass Cytometry: Application to Chronic Lymphocytic Leukemia.

Method for the Analysis of the Tumor Microenvironment by Mass Cytometry: Application to Chronic Lymphocytic Leukemia.

Journal: Frontiers in immunology

Published: June 30, 2020

The B-side of Cancer Immunity: The Underrated Tune.

The B-side of Cancer Immunity: The Underrated Tune.

Journal: Cells

Published: April 01, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026